Developing advanced drug delivery systems to improve medication effectiveness
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
This study is looking at new ways to deliver medications that can help people with chronic conditions take their medicine more easily and safely, by using special materials that release the drugs slowly over time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rice University NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11140698 on NIH RePORTER |
What this research studies
This research focuses on creating innovative parenteral drug delivery systems that can better control how medications are released in the body. By utilizing advanced materials and techniques, the goal is to enhance the safety and efficacy of drug therapies, making it easier for patients to adhere to their medication regimens. The approach involves using biodegradable materials to encapsulate drugs, allowing for sustained release and reducing the need for frequent dosing. This could significantly improve treatment outcomes for patients with chronic conditions who struggle with medication adherence.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with chronic diseases who require regular medication and may struggle with adherence to their treatment plans.
Not a fit: Patients who do not require injectable medications or those with acute conditions that do not necessitate long-term drug delivery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and convenient medication options for patients, ultimately improving health outcomes.
How similar studies have performed: Previous research has shown promise in developing controlled-release drug delivery systems, indicating that this approach has potential for success.
Where this research is happening
Houston, United States
- Rice University — Houston, United States (Active)
Researchers
- Principal investigator: Mchugh, Kevin James — Rice University
- Study coordinator: Mchugh, Kevin James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.